FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975389099> ?p ?o ?g. }

• W2975389099 endingPage "108" @default.
• W2975389099 startingPage "98" @default.
• W2975389099 abstract "Introduction Previous studies suggested that epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitor (TKIs) plus bevacizumab could significantly prolong progression-free survival (PFS) than EGFR-TKI alone as first-line setting for patients with EGFR-mutant non-small-cell lung cancer (NSCLC). However, whether this combination could benefit patients with multiple brain metastases (BrMs) remains undetermined. Methods A total of 208 patients with EGFR-mutant NSCLC and multiple BrM (number >3, at least one of lesions was measurable) were retrospectively identified. Kaplan-Meier curves with two-sided log-rank tests and Cox proportional hazards model with calculated hazard ratios and 95% confidence intervals were used to determine the survival difference. Results Of all patients, 149 patients received EGFR-TKIs monotherapy and 59 received EGFR-TKIs plus bevacizumab as first-line setting. EGFR-TKIs plus bevacizumab was associated with a significantly higher intracranial objective response rate (ORR, 66.1% vs. 41.6%, P = 0.001), systemic ORR (74.6% vs. 57.1%, P = 0.019), longer intracranial PFS (14.0 vs. 8.2 months; P < 0.001) and systemic PFS (14.4 vs. 9.0 months; P < 0.001). Importantly, addition of bevacizumab also had a significantly longer overall survival (OS, 29.6 vs. 21.7 months; P < 0.001). Multivariate analysis consistently revealed that addition of bevacizumab was independently associated with prolonged intracranial and systemic PFS, and OS. No unexpected serious adverse effects were observed. Conclusions EGFR-TKIs plus bevacizumab prolonged not only PFS but also OS in patients with EGFR-mutant NSCLC and multiple BrMs when compared with EGFR-TKIs alone, indicating that this combination could be an alternative therapeutic option for those patients." @default.
• W2975389099 created "2019-10-03" @default.
• W2975389099 creator A5016049048 @default.
• W2975389099 creator A5021941803 @default.
• W2975389099 creator A5023366097 @default.
• W2975389099 creator A5029411467 @default.
• W2975389099 creator A5030449789 @default.
• W2975389099 creator A5055029433 @default.
• W2975389099 creator A5057960953 @default.
• W2975389099 creator A5076756498 @default.
• W2975389099 creator A5080382748 @default.
• W2975389099 date "2019-11-01" @default.
• W2975389099 modified "2023-10-15" @default.
• W2975389099 title "EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases" @default.
• W2975389099 cites W1497381120 @default.
• W2975389099 cites W1998193510 @default.
• W2975389099 cites W2007553857 @default.
• W2975389099 cites W2012295597 @default.
• W2975389099 cites W2043166238 @default.
• W2975389099 cites W2049674541 @default.
• W2975389099 cites W2068554857 @default.
• W2975389099 cites W2111662961 @default.
• W2975389099 cites W2118349377 @default.
• W2975389099 cites W2129360604 @default.
• W2975389099 cites W2136371443 @default.
• W2975389099 cites W2136601558 @default.
• W2975389099 cites W2150335765 @default.
• W2975389099 cites W2160982674 @default.
• W2975389099 cites W2302258098 @default.
• W2975389099 cites W2340863814 @default.
• W2975389099 cites W2397460919 @default.
• W2975389099 cites W2495949753 @default.
• W2975389099 cites W2606131767 @default.
• W2975389099 cites W2747651708 @default.
• W2975389099 cites W2762761278 @default.
• W2975389099 cites W2766057609 @default.
• W2975389099 cites W2767103404 @default.
• W2975389099 cites W2791483720 @default.
• W2975389099 cites W2794369901 @default.
• W2975389099 cites W2802142055 @default.
• W2975389099 cites W2887416920 @default.
• W2975389099 cites W2891454322 @default.
• W2975389099 cites W2898368098 @default.
• W2975389099 cites W2937223370 @default.
• W2975389099 cites W2947350492 @default.
• W2975389099 cites W3138686398 @default.
• W2975389099 doi "https://doi.org/10.1016/j.ejca.2019.08.021" @default.
• W2975389099 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31569068" @default.
• W2975389099 hasPublicationYear "2019" @default.
• W2975389099 type Work @default.
• W2975389099 sameAs 2975389099 @default.
• W2975389099 citedByCount "35" @default.
• W2975389099 countsByYear W29753890992020 @default.
• W2975389099 countsByYear W29753890992021 @default.
• W2975389099 countsByYear W29753890992022 @default.
• W2975389099 countsByYear W29753890992023 @default.
• W2975389099 crossrefType "journal-article" @default.
• W2975389099 hasAuthorship W2975389099A5016049048 @default.
• W2975389099 hasAuthorship W2975389099A5021941803 @default.
• W2975389099 hasAuthorship W2975389099A5023366097 @default.
• W2975389099 hasAuthorship W2975389099A5029411467 @default.
• W2975389099 hasAuthorship W2975389099A5030449789 @default.
• W2975389099 hasAuthorship W2975389099A5055029433 @default.
• W2975389099 hasAuthorship W2975389099A5057960953 @default.
• W2975389099 hasAuthorship W2975389099A5076756498 @default.
• W2975389099 hasAuthorship W2975389099A5080382748 @default.
• W2975389099 hasConcept C121608353 @default.
• W2975389099 hasConcept C126322002 @default.
• W2975389099 hasConcept C143998085 @default.
• W2975389099 hasConcept C197934379 @default.
• W2975389099 hasConcept C207103383 @default.
• W2975389099 hasConcept C2776256026 @default.
• W2975389099 hasConcept C2776694085 @default.
• W2975389099 hasConcept C2777802072 @default.
• W2975389099 hasConcept C2778087573 @default.
• W2975389099 hasConcept C2779438470 @default.
• W2975389099 hasConcept C2780739268 @default.
• W2975389099 hasConcept C44249647 @default.
• W2975389099 hasConcept C50382708 @default.
• W2975389099 hasConcept C71924100 @default.
• W2975389099 hasConceptScore W2975389099C121608353 @default.
• W2975389099 hasConceptScore W2975389099C126322002 @default.
• W2975389099 hasConceptScore W2975389099C143998085 @default.
• W2975389099 hasConceptScore W2975389099C197934379 @default.
• W2975389099 hasConceptScore W2975389099C207103383 @default.
• W2975389099 hasConceptScore W2975389099C2776256026 @default.
• W2975389099 hasConceptScore W2975389099C2776694085 @default.
• W2975389099 hasConceptScore W2975389099C2777802072 @default.
• W2975389099 hasConceptScore W2975389099C2778087573 @default.
• W2975389099 hasConceptScore W2975389099C2779438470 @default.
• W2975389099 hasConceptScore W2975389099C2780739268 @default.
• W2975389099 hasConceptScore W2975389099C44249647 @default.
• W2975389099 hasConceptScore W2975389099C50382708 @default.
• W2975389099 hasConceptScore W2975389099C71924100 @default.
• W2975389099 hasFunder F4320333688 @default.
• W2975389099 hasLocation W29753890991 @default.
• W2975389099 hasLocation W29753890992 @default.
• W2975389099 hasOpenAccess W2975389099 @default.

• next